With 1.68 lakh vaccine doses administered in Delhi Saturday, the capital has crossed the milestone of 1 crore people being administered at least one vaccine dose.
As per government estimates, Delhi has a population of approximately 2 crore, of which 1.5 crore are over the age of 18 and eligible for COVID vaccination. With the highest number of vaccine doses this week administered Saturday, 1,40,95,736 doses have been administered in Delhi since the start of the city’s vaccination drive, of which 1,00,40,983 are first doses—which could mean that more than 1 crore, or two-third have received at least one dose. This places Delhi far ahead of the national vaccine coverage, which is currently at a little over 55 per cent of India’s eligible population having received at least one dose. However, it should be noted that the Delhi numbers refer to vaccines administered in Delhi and could also include residents of nearby areas who might have been vaccinated in the city.
In other news, a new study shows that people with uncomplicated liver transplant and with no co-morbidities did “not have poor outcome” if they were affected by Covid. The independent study was conducted by Max Super Speciality Hospital, Saket, under the aegis of Dr Subhash Gupta, the chairman of the hospital’s centre for liver biliary sciences. The study was conducted on a batch of people who went liver transplant since 2006, including those affected by COVID-19, to understand their response, as they are on “immunosuppressive medications” which predispose them to infections.